Chemically-modified human growth hormone conjugates
CA 2467731 A1 · Owner: Lao, Wei · Inventors: Finn, Rory F.; Siegel, Ned R.; Lao, Wei
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a chemically modified human Growth Hormone (hGH) prepared by binding a water soluble polymer to the protein. The chemically-modified protein according to the present invention may have a much longer lasting hGH activity than that of the unmodified hGH enabling reduced , dose and scheduling opportunities.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 20, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 20, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 20, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.